Get started
Author

Kazunori Samata

OpenAlex ID: A5020105653
Chemical removal of the endothelium by saponin in the isolated dog femoral artery
1986 · Kazunori Samata, Tomohiko Kimura, et al. · European Journal of Pharmacology · 39
Mechanism of action of aragusterol a (YTA0040), a potent anti-tumor marine steroid targeting the G1 phase of the cell cycle
2000 · Kazuya Fukuoka, Takehiro Yamagishi, et al. · International Journal of Cancer · 30
PDF
A novel low molecular weight antagonist of vascular endothelial growth factor receptor binding: VGA1155.
2003 · Yasuji Ueda, Takehiro Yamagishi, et al. · PubMed · 22
VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo.
2004 · Yasuji Ueda, Takehiro Yamagishi, et al. · PubMed · 15
In vivo activity on murine tumors of a novel antitumor compound, N-?-dimethylaminoethyl 9-carboxy-5-hydroxy-10-methoxybenzo[a]phenazine-6-carboxamide sodium salt (NC-190)
1989 · Shiro Nakaike, Takehiro Yamagishi, et al. · Cancer Chemotherapy and Pharmacology · 15
A novel low molecular weight VEGF receptor-binding antagonist, VGA1102, inhibits the function of VEGF and in vivo tumor growth
2004 · Yasuji Ueda, Takehiro Yamagishi, et al. · Cancer Chemotherapy and Pharmacology · 12
Novel water-soluble analogues retaining potent antitumor activity of RA-VII, a cyclic hexapeptide from Rubia plants
1997 · Yukio Hitotsuyanagi, Yoshiaki Anazawa, et al. · Bioorganic & Medicinal Chemistry Letters · 9
Establishment and characterization of a mouse FM3A cell mutant resistant to topoisomerase II-inhibitor NC-190
2002 · Kazunori Samata, Takehiro Yamagishi, et al. · Cancer Chemotherapy and Pharmacology · 8
Antitumor effects of synthetic VEGF-receptor binding antagonist, VGA1155.
2005 · Yasuji Ueda, Takehiro Yamagishi, et al. · PubMed · 7
The topoisomerase II-inhibitor NC-190 reduces the level of thymidine kinase mRNA in murine tumor cells.
2002 · Kazunori Samata, Takehiro Yamagishi, et al. · PubMed · 2
Works count: 10
Citation count: 159
H-index: 8
I10-index: 6
Year
Topic
Type